| 1. |
盧青, 孫丹, 劉智勝. 中國抽動障礙診斷和治療專家共識解讀. 中華實用兒科臨床雜志, 2021, 36(9): 647-653.
|
| 2. |
洪震, 姜玉武. 臨床診療指南癲癇病分冊. 北京: 人民衛生出版社, 2023: 12.
|
| 3. |
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terninology, 2005-2009. Epilepsia, 2010, 51(4): 676-685.
|
| 4. |
Smith KM, Wirrell EC, Andrade DM, et al. Clinical presentation and evaluation of epilepsy with eyelid myoclonia: results of an international expert consensus panel. Epilepsia, 2023, 64(9): 2330-2341.
|
| 5. |
羅結儀, 齊霜, 鄭舒暢. Jeavons綜合征的研究進展. 中華神經醫學雜志, 2020, 19(3): 302-305.
|
| 6. |
Covants A. Jeavons syndrome-updated review. J Epileptol, 2015, 23(2): 113-123.
|
| 7. |
Wang XL, Bao JX, Liangs, et al. Jeavous syndrome in China. Epilepsy Behav, 2014, 32: 64-71.
|
| 8. |
Renganathan R, Delanty N. Juvenile myoclonic epilepsy: underappreciated and under-diagnosed. Postgrad Med, 2003, 79: 78-80.
|
| 9. |
Jayalakshmi SS, Srinivasa Rao B, Sailaja S. Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy. Acta Neurol Scand, 2010, 122(2): 115-123.
|
| 10. |
Hrachovy RA, Frost JD. The EEG in selected generalized seizures. J Clin Neurophysiol, 2006, 23(4): 312-332.
|
| 11. |
湯業磊, 張進, 丁美萍. 青少年肌陣攣性癲癇87例臨床及治療特點分析. 中華神經科雜志, 2006, 39(5): 316-319.
|
| 12. |
Chowdhury A, Brodie MJ. Pharmacological outcomes in juvenile myoclonic epilepsy: support for sodium valproate. Epilepsy Res, 2016, 119(1): 62-66.
|
| 13. |
Zhang Y, Chen J, Ren J, et al. Clinical features and treatment outcomes of Juvenile myoclonic epilepsy patients. Epilepsia Open, 2019, 4(2): 302.
|